A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

10.1186/s12885-020-07616-4

Saved in:
Bibliographic Details
Main Authors: Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: BioMed Central Ltd 2021
Subjects:
Advanced solid tumours
Anti-angiogenic
Docetaxel
Short-course sunitinib
Tumour vasculature
Online Access:https://scholarbank.nus.edu.sg/handle/10635/199287
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1186/s12885-020-07616-4

Similar Items